Aptevo Therapeutics (AP82) Cash flow

0 Followers

Aptevo Therapeutics Cash Flow

DE:AP82's free cash flow for Q2 2026 was $-5.45M. For the 2026 fiscal year, DE:AP82's free cash flow was decreased by $-1.81M and operating cash flow was $-5.45M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	$ -25.59M	$ -23.79M	$ -11.73M	$ -21.02M	$ -21.68M
Investing Cash Flow	$ 0.00	$ 0.00	$ 0.00	$ -29.00K	$ -713.00K
Financing Cash Flow	$ 38.50M	$ 15.60M	$ 6.00M	$ -2.62M	$ 26.16M
End Cash Position	$ 21.62M	$ 8.71M	$ 16.90M	$ 22.64M	$ 46.30M
Free Cash Flow	$ -25.59M	$ -23.79M	$ -11.73M	$ -21.05M	$ -22.39M

Currency in USD